Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03070899 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 1) | completed | Phase 3 | 526 | ObsEva SAINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04909814 | Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination | completed | — | 160 | Falu HospitalOTHER | 1 | Jun 7, 2021 | clinicaltrials |
| NCT04909281 | Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders | completed | — | 741 | Falu HospitalOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT02420665 | Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia | completed | Early Phase 1 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2021 | clinicaltrials |
| NCT04905576 | Quality of Life Interventions During Cervical Cancer Treatment | completed | N/A | 60 | University of IowaOTHER | 0 | May 27, 2021 | clinicaltrials |
| NCT01953107 | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | completed | Phase 4 | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT02896413 | The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection | completed | N/A | 100 | Yonsei UniversityOTHER | 1 | May 4, 2021 | clinicaltrials |
| NCT02269293 | Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers | completed | Phase 1 | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 23, 2021 | clinicaltrials |
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | completed | Phase 1 | 11 | Susana M. Campos, MDOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | completed | N/A | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03813940 | Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | completed | Phase 1 | 24 | Xiamen UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03935204 | Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | completed | Phase 2 | 627 | Xiamen UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04809727 | Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy(HSTH) | completed | N/A | 88 | Tanta UniversityOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04830332 | Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor Histology | completed | N/A | 50 | Erdemli State HospitalOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT03908996 | the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer | completed | N/A | 25 | Sanford HealthOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT03070951 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 2) | completed | Phase 3 | 511 | ObsEva SAINDUSTRY | 9 | Mar 5, 2021 | clinicaltrials |
| NCT03824613 | Urinary miRNA in Endometrial Cancer Study | completed | — | 164 | Royal Cornwall Hospitals TrustOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03021720 | Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial(SPARQLE) | completed | N/A | 40 | Mount Sinai Hospital, CanadaOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT01569672 | Ohio Patient Navigator Research Program(OPNRP) | completed | N/A | 941 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT02172911 | A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer | completed | Phase 1 / Phase 2 | 10 | Inovio PharmaceuticalsINDUSTRY | 1 | Feb 21, 2021 | clinicaltrials |
| NCT03444987 | The Role of Fibroblast Activation in Uterine Fibroid | completed | — | 35 | Assiut UniversityOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT01627288 | Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)(IDEAL) | completed | N/A | 12 | Duke UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT01365156 | Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix | completed | Phase 3 | 28 | M.D. Anderson Cancer CenterOTHER | 2 | Feb 3, 2021 | clinicaltrials |
| NCT02682693 | Denosumab as an add-on Neoadjuvant Treatment (GeparX)(GeparX) | completed | Phase 2 | 780 | GBG Forschungs GmbHOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT02725489 | Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers | completed | Phase 2 | 13 | Mary Crowley Medical Research CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT02594826 | Cervical Cancer Screening Intervention Among Korean American Women | completed | N/A | 744 | Fox Chase Cancer CenterOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT01840124 | Uterine Leiomyoma Treatment With Radiofrequency Ablation(ULTRA) | completed | N/A | 26 | University of California, San FranciscoOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03697226 | Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. | completed | Phase 1 | 8 | Antiva BiosciencesINDUSTRY | 1 | Jan 13, 2021 | clinicaltrials |
| NCT01851772 | Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer | completed | N/A | 3 | Xoft, Inc.INDUSTRY | 1 | Jan 12, 2021 | clinicaltrials |
| NCT01101750 | Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? | completed | Phase 4 | 25 | Medstar Health Research InstituteOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT03137563 | Acceptability of HPV-self Sampling | completed | — | 356 | University Hospital, MontpellierOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT01338831 | Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer | completed | Phase 1 | 73 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 17, 2020 | clinicaltrials |
| NCT02934724 | Impact of HPV Vaccine On The Prevalence Of HPV In Norway | completed | — | 315 | Oslo University HospitalOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT02506816 | Preoperative Olaparib Endometrial Carcinoma Study (POLEN)(Polen) | completed | — | 36 | MedSIROTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT02093598 | POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus(POEM) | completed | Phase 2 | 10 | MedSIROTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT02260752 | Patient Centered Results for Uterine Fibroids(COMPARE-UF) | completed | — | 3,094 | Duke UniversityOTHER | 1 | Nov 18, 2020 | clinicaltrials |
| NCT00879840 | Assessment of Screening Modalities for Gynecologic Cancers | completed | — | 118 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2020 | clinicaltrials |
| NCT01793545 | Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples | completed | — | 1,932 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2020 | clinicaltrials |
| NCT00340600 | Continuation of Follow-up of DES-Exposed Cohorts | completed | — | 10,805 | National Cancer Institute (NCI)NIH | 1 | Nov 16, 2020 | clinicaltrials |
| NCT04626895 | Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers | completed | N/A | 15 | Medstar Health Research InstituteOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT03744507 | Bone Mineral Density in Women With Uterine Fibroids or Endometriosis | completed | — | 660 | Myovant Sciences GmbHINDUSTRY | 7 | Nov 10, 2020 | clinicaltrials |
| NCT04617236 | Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women(CLS) | completed | N/A | 444 | University of Puerto RicoOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT00444054 | The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer(RECHARGE) | completed | N/A | 10 | Albert Einstein College of MedicineOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT03538028 | A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies | completed | Phase 1 | 22 | Incyte Biosciences International SàrlINDUSTRY | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00453661 | Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities | completed | — | 2,472 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 29, 2020 | clinicaltrials |
| NCT02283658 | Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 | 20 | Mayo ClinicOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT00006027 | Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Oct 22, 2020 | clinicaltrials |
| NCT01935973 | Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 1 | 26 | National Cancer Institute (NCI)NIH | 1 | Oct 14, 2020 | clinicaltrials |
| NCT04237090 | Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel(PREMED-F1) | completed | Phase 3 | 27 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Oct 12, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Jun 9, 2021source: clinicaltrials